Dr. Reddys - Dr. Reddy's Laboratories Share Price

Dr. Reddys - Dr. Reddy's Laboratories Share Price

  • 1,271.703.21 (0.26%)
  • Closed
  • As On: 10 Jun, 2026, 03:46 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Try ETMarkets GPTNEW
Open1,268.60
High1,283.70
Low1,266.70
Prev Close1,268.50
Volume11,72,140
VWAP(₹)1,273.84

Key Metrics

PE Ratio(x)25.30
EPS - TTM(₹)50.27
MCap(₹ Cr.)1,06,143
MCap Rank6
PB Ratio(x)2.77
Div Yield(%)0.63
Face Value(₹)1.00
52W High(₹)1,379.70
52W Low(₹)1,148.40
MCap/Sales3.11
Beta(1 Month)0.75
BV/Share(₹)458.04

Dr. Reddys share price insights

Rank 89 - ET 5002025 ranking

  • Dividend Announcement

    Company announced a dividend of Rs 8.0 per share on May 12, 2026 with record date of Jul 10, 2026.

  • Quarterly Topline Performance

    Company witnessed QoQ revenue decline of 11.09%, which is lowest in the last 3 years. (Source: Consolidated Financials)

  • Employee & Interest Expense

    Company has spent 1.11% of its operating revenues towards interest expenses and 17.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

  • Dr. Reddys Share Price Update

    Dr. Reddy's Laboratories Ltd. share price moved up by 0.26% from its previous close of Rs 1,268.50. Dr. Reddy's Laboratories Ltd. stock last traded price is 1,271.70

    Share PriceValue
    Today/Current/Last1,271.70
    Previous Day1,268.50

Found Insights useful?

Dr. Reddys Share Price Returns

1 Day0.26%
1 Month-1.72%
3 Months-3.26%
1 Year-5.72%
3 Years36.25%
5 Years20.15%

Dr. Reddys Share Recommendations

Mean recosCurrent
HOLD

38 Analysts

Strong
SellSellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy6667
Buy12121110
Hold99910
Sell7787
Strong Sell4444
# Analysts38383838
Recent Recos
  • Target₹1418
  • OrganizationJM Financial
  • BUY
  • Target₹1737
  • OrganizationJM Financial
  • BUY
  • Target₹8010
  • OrganizationJM Financial
  • BUY
View all Stock Recommendations

News & Analysis

View all Dr. Reddys Share News & Announcements

Financials

  • Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income9,022.209,152.208,862.409,050.508,531.40
    Total Income Growth (%)-1.423.27-2.086.082.23
    Total Expenses7,386.907,323.006,874.606,985.206,579.60
    Total Expenses Growth (%)0.876.52-1.586.163.47
    EBIT1,635.301,829.201,987.802,065.301,951.80
    EBIT Growth (%)-10.60-7.98-3.755.82-1.77
    Profit after Tax (PAT)1,209.901,347.101,418.101,593.301,413.70
    PAT Growth (%)-10.18-5.01-11.0012.7012.58
    EBIT Margin (%)18.1319.9922.4322.8222.88
    Net Profit Margin (%)13.4114.7216.0017.6016.57
    Basic EPS (₹)14.5316.1817.0419.1216.97
    Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income4,643.004,982.808,207.805,977.305,250.40
    Total Income Growth (%)-6.82-39.2937.3213.84-23.95
    Total Expenses4,497.404,433.104,252.304,384.404,087.70
    Total Expenses Growth (%)1.454.25-3.017.26-3.47
    EBIT145.60549.703,955.501,592.901,162.70
    EBIT Growth (%)-73.51-86.10148.3237.00-56.44
    Profit after Tax (PAT)90.60387.302,961.201,200.70849.40
    PAT Growth (%)-76.61-86.92146.6241.36-54.87
    EBIT Margin (%)3.1411.0348.1926.6522.14
    Net Profit Margin (%)1.957.7736.0820.0916.18
    Basic EPS (₹)1.094.6535.5914.4110.20
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue33,741.2028,905.4025,725.2022,029.6019,338.90
    Total Revenue Growth (%)16.7312.3616.7813.916.62
    Total Expenses26,083.4021,719.1019,713.7019,038.5016,503.40
    Total Expenses Growth (%)20.0910.173.5515.361.20
    Profit after Tax (PAT)5,655.105,577.904,507.302,182.501,951.60
    PAT Growth (%)1.3823.75106.5211.83-3.67
    Operating Profit Margin (%)24.3226.2624.9414.3215.39
    Net Profit Margin (%)17.3219.9118.2710.1210.24
    Basic EPS (₹)67.89335.22271.47131.57117.67
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue24,118.8020,346.1017,553.8014,887.2014,150.20
    Total Revenue Growth (%)18.5415.9117.915.2112.36
    Total Expenses16,882.9014,554.8013,687.8012,663.4011,094.00
    Total Expenses Growth (%)16.006.338.0914.1513.00
    Profit after Tax (PAT)5,349.404,342.002,612.801,623.202,186.40
    PAT Growth (%)23.2066.1860.97-25.76-25.57
    Operating Profit Margin (%)31.7729.8322.8915.7023.24
    Net Profit Margin (%)23.1422.2815.4011.2616.37
    Basic EPS (₹)64.22260.95157.3797.85131.84

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Quarterly Topline Performance

      Company witnessed QoQ revenue decline of 11.09%, which is lowest in the last 3 years. (Source: Consolidated Financials)

    • Employee & Interest Expense

      Company has spent 1.11% of its operating revenues towards interest expenses and 17.78% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets49,426.6038,863.8032,285.1029,746.9026,616.80
    Total Assets Growth (%)27.1820.388.5311.7614.60
    Total Liabilities15,499.2010,609.008,999.0010,534.508,975.10
    Total Liabilities Growth (%)46.0917.89-14.5817.3717.68
    Total Equity33,927.4028,254.8023,286.1019,212.4017,641.70
    Total Equity Growth (%)20.0821.3421.208.9013.10
    Current Ratio (x)1.922.592.381.821.80
    Total Debt to Equity (x)0.120.060.050.160.15
    Contingent Liabilities1,738.102,091.80997.40936.801,077.40
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets38,290.9030,359.3025,374.8024,495.6021,629.60
    Total Assets Growth (%)26.1319.643.5913.2511.06
    Total Liabilities9,434.306,118.504,900.606,159.404,645.90
    Total Liabilities Growth (%)54.1924.85-20.4432.588.45
    Total Equity28,856.6024,240.8020,474.2018,336.2016,983.70
    Total Equity Growth (%)19.0418.4011.667.9611.79
    Current Ratio (x)1.913.223.112.232.40
    Total Debt to Equity (x)0.120.030.000.120.07
    Contingent Liabilities1,432.611,763.60830.20827.401,062.80

    All figures in Rs Cr, unless mentioned otherwise

    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities4,642.804,543.305,887.502,810.803,570.30
    Net Cash used in Investing Activities-5,807.70-4,028.30-4,137.30-2,638.70-2,266.00
    Net Cash flow from Financing Activities1,891.10-376.30-2,686.10-242.20-29.80
    Net Cash Flow748.60132.80-907.303.201,285.80
    Closing Cash & Cash Equivalent1,459.30710.70577.901,485.201,482.00
    Closing Cash & Cash Equivalent Growth (%)105.3322.98-61.090.22655.35
    Total Debt/ CFO (x)0.900.360.191.100.75
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities4,225.003,449.705,052.901,338.703,514.20
    Net Cash used in Investing Activities-5,697.60-3,430.30-3,447.60-2,038.00-1,458.00
    Net Cash flow from Financing Activities1,590.7068.10-2,696.90505.50-794.30
    Net Cash Flow118.3089.10-1,047.10-145.901,266.30
    Closing Cash & Cash Equivalent319.70201.40112.301,159.501,305.40
    Closing Cash & Cash Equivalent Growth (%)58.7479.34-90.31-11.183,238.62
    Total Debt/ CFO (x)0.800.210.001.620.34

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Increase in Cash from Investing

      Company has used Rs 6549.3 cr for investing activities which is an YoY increase of 12.77%. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)16.8519.7419.3511.3511.06
    Return on Capital Employed (%)21.8125.1325.9515.4415.84
    Return on Assets (%)11.4414.3513.967.337.33
    Interest Coverage Ratio (x)34.0951.5951.8544.3942.90
    Asset Turnover Ratio (x)0.740.790.800.560.60
    Price to Earnings (x)16.8918.4217.0932.8938.61
    Price to Book (x)2.843.633.313.734.26
    EV/EBITDA (x)10.1111.6210.3217.0118.20
    EBITDA Margin (%)29.5431.5130.0119.7321.84
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)18.5317.9112.768.8512.87
    Return on Capital Employed (%)24.7823.4118.5412.2518.17
    Return on Assets (%)13.9714.3010.296.6210.10
    Interest Coverage Ratio (x)76.30311.41284.3880.9584.32
    Asset Turnover Ratio (x)0.670.700.680.620.65
    Price to Earnings (x)17.8623.7029.5044.2534.48
    Price to Book (x)3.314.243.763.914.42
    EV/EBITDA (x)11.6715.0515.8923.3418.96
    EBITDA Margin (%)36.2734.8428.3321.3529.49

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

  • Stochastic Crossover

    Bearish signal on weekly chart

    Appeared on: 5 Jun 2026

    Region: Equlibrium

    Last Signal 22 May 2026 (Loss -0.74%)

    Average price decline of -5.31% within 7 weeks of Bearish signal in last 10 years

  • 47%
    Positive Movement
    since 1st Jan 2005
    on basis
    53%
    Negative Movement
    since 1st Jan 2005
    on basis
    Exclude

    Global Meltdown1st Jan 2008 to 10th Nov 2008

    Covid Crisis1st Feb 2020 to 31st Mar 2020

  • R11282.77Pivot

    1274.73

    		S11265.77
    R21291.73S21257.73
    R31308.73S31240.73
  • 5 Days14 Days28 Days
    23.9828.8631.30

Found Technicals useful?

Peer Comparison

Found Peer Comparison useful?

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters22,23,05,64026.63 %-0.01
    Pledge00.00 %0.00
    FII17,64,85,06221.14 %-1.19
    DII25,58,96,59030.66 %0.23
    MF11,01,32,05413.19 %-0.67
    Others17,99,69,67821.57 %0.98
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters26.6326.6426.6426.64
    Pledge0.000.000.000.00
    FII21.1422.3424.6825.33
    DII30.6630.4327.9726.71
    Mutual Funds13.1913.8713.3113.61
    Others21.5720.5920.7121.31

Mutual Funds Ownership

MF Ownership as on 30 April 2026

View all Mutual Fund Schemes

Dr. Reddys Futures & Options

    DatePriceOpen Interest

    30-06-2026Current

    22.80-0.40 (-1.72%)

    4,23,12518,125 (4.48%)

    26.00
    Open
    30.40
    High
    21.65
    Low
    23.20
    Close
    2,880
    Contracts Traded
    9,403.78
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

    • Expiry Month
    DatePriceOpen Interest

    30-06-2026Current

    1,272.100.80 (0.06%)

    1,50,40,00087,500 (0.59%)

    1,275.00
    Open
    1,287.30
    High
    1,270.90
    Low
    1,271.30
    Prev Close
    5,135
    Contracts Traded
    16,393.23
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

Dr. Reddys Top Searches

    Corporate Actions

    • Final

      800%

      May 12, 2026

      Board Meeting

      Audited Results

      Mar 23, 2026

      Board Meeting

      Quarterly Results

      Dec 23, 2025

    • Announced onMeeting on
      Mar 23, 2026May 12, 2026
      Audited Results
      Dec 23, 2025Jan 21, 2026
      Quarterly Results
      Sep 22, 2025Oct 24, 2025
      Quarterly Results
      Jun 23, 2025Jul 23, 2025
      Quarterly Results
      Mar 24, 2025May 09, 2025
      Audited Results, Dividend & Others
    • Announced onEx-DateDividend%
      May 12, 2026Jul 10, 2026800%
      May 09, 2025Jul 10, 2025800%
      May 07, 2024Jul 16, 2024800%
      May 10, 2023Jul 11, 2023800%
      May 19, 2022Jul 11, 2022600%
    • Announced onEx-Date
      May 31, 2006Aug 28, 2006
      Bonus Ratio: 1 share(s) for every 1 shares held
      Mar 24, 1994Apr 08, 1994
      Bonus Ratio: 2 share(s) for every 1 shares held
      Sep 30, 1992Dec 04, 1992
      Bonus Ratio: 1 share(s) for every 1 shares held
      Dec 03, 1991-
      Bonus Ratio: 1 share(s) for every 2 shares held
    • Announced onEx-Date
      Jul 27, 2024Oct 28, 2024
      Split: Old FV5.0| New FV:1.0
      Jul 31, 2001Oct 10, 2001
      Split: Old FV10.0| New FV:5.0

    • No Data Available

    • Announced onMeeting on
      May 09, 2025Jul 24, 2025
      -
      Aug 16, 2024Sep 14, 2024
      -
      May 07, 2024Jul 29, 2024
      Book closure from Jul 17, 2024 to Jul 19, 2024
      Jan 15, 2024Feb 15, 2024
      -
      Oct 16, 2023Nov 16, 2023
      -

    About Dr. Reddys

    Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 1,06,143.33 Crore) operating in Pharmaceuticals sector.

    Show More

    Industry

    Pharma - Indian

    Key Indices Listed On

    Nifty 50, Nifty 100, Nifty 200, Nifty 500, BSE 500

    Address

    8-2-337, Road No. 3,Banjara Hills,Hyderabad, Telangana - 500034

    Contact

    shares@drreddys.com

    http://www.drreddys.com

    Executive Leadership

    GV

    G V Prasad

    Co-Chairman & Manag. Director
    KS

    K Satish Reddy

    Chairman
    EI

    Erez Israeli

    Chief Executive Officer
    DS

    Deepak Sapra

    CEO - API & Services
    Show More

    Auditors

    S R Batliboi & Associates LLP

    Brands

    FAQs about Dr. Reddys share

    • 1. What is Dr. Reddys share price and what are the returns for Dr. Reddys share?
      Dr. Reddys share price is Rs 1,271.70 as on 10 Jun, 2026, 03:46 PM IST. Dr. Reddys share price is up by 0.26% based on previous share price of Rs. 1275.6.
    • 2. What is 52 week high/low of Dr. Reddys share price?
      52 Week high of Dr. Reddys share is Rs 1,379.70 while 52 week low is Rs 1,148.40
    • 3. What is the PE & PB ratio of Dr. Reddys?
      The PE ratio of Dr. Reddys stands at 25.23, while the PB ratio is 2.77.
    • 4. What are the returns for Dr. Reddys share?
      Return Performance of Dr. Reddys Shares:
      • 1 Week: Dr. Reddys share price moved up by 0.66%
    • 5. What's the market capitalization of Dr. Reddys?
      Market Capitalization of Dr. Reddys stock is Rs 1,06,143 Cr.

    Top Gainers

    As on 03:59 PM | 10 Jun 2026
    Inox India
    1,891.60
    204.90 (12.15%)
    Akums Drugs & Pharma
    592.10
    43.86 (8.00%)
    Chambal Fertilisers
    477.65
    22.90 (5.04%)
    Afcons Infrastru
    330.05
    14.56 (4.62%)
    Concord Biotech Ltd.
    1,330.70
    58.50 (4.60%)

    Top Losers

    As on 03:59 PM | 10 Jun 2026
    Oil India Ltd
    427.35
    -48.60 (-10.22%)
    IFCI
    71.83
    -5.24 (-6.80%)
    Manappuram Finance
    288.25
    -19.00 (-6.19%)
    Jindal Saw
    225.16
    -14.66 (-6.11%)
    NLC India
    309.60
    -18.15 (-5.54%)

    Equity Quick Links

    Top Gainers
    Top Losers
    Hourly gainers
    Hourly losers
    Sensex
    Nifty
    NSE
    BSE
    Midcap stocks
    Smallcap stocks
    Largecap stocks
    Sensex
    Nifty
    NSE
    BSE
    MCX Live

    More from Markets

    IPO
    Stock market news
    Budget 2022 Live Updates
    Cryptocurrency
    Currency converter
    NSE holiday list

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    Business News › Markets › Stocks › Stock Price Quotes › Dr. Reddys Share Price

    Browse Companies

    ABCDEFGHIJKLMNOPQRSTUVWXYZ
    123456789

    Popular Categories

    Hot on Web

    In Case you missed it

    Top Searched Companies

    Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
    Times Syndication Service

    Do Not Sell My Personal Information